Published in Adv Neurol on January 01, 1988
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry (2004) 1.96
The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain (2008) 1.82
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience (2013) 1.20
Animal models for dystonia. Mov Disord (2013) 0.95
Reduced striatal D2 receptor binding in myoclonus-dystonia. Eur J Nucl Med Mol Imaging (2008) 0.89
Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia. Ann Neurol (2002) 0.89
Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management. Curr Neuropharmacol (2012) 0.86
Secondary blepharospasm associated with structural lesions of the brain. J Neurol Sci (2013) 0.82
Focal hand dystonia secondary to Basal Ganglia germinoma. J Clin Neurol (2007) 0.77
A rat model of hemidystonia induced by 3-nitropropionic acid. PLoS One (2013) 0.76
Dementia paralytica: deterioration from communicating hydrocephalus. J Neurol Neurosurg Psychiatry (1979) 1.42
[Arnold-Chiari malformation with multiple paroxysmal manifestations induced by coughing]. Neurologia (1992) 1.36
[Brain dynamics according to Justo Gonzalo]. Neurologia (2004) 1.08
Nummular headache secondary to an intracranial mass lesion. Cephalalgia (2007) 1.04
Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord (1992) 1.01
Tabetic lightning pains: high-dosage intravenous penicillin versus carbamazepine therapy. Eur Neurol (1981) 0.99
Abnormalities of Bell's phenomenon in amyotrophic lateral sclerosis: a clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry (1978) 0.95
Sensory ataxic hemiparesis in thalamic hemorrhage. Stroke (1990) 0.92
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study. J Neural Transm (Vienna) (2003) 0.91
Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics. Eur Neurol (1984) 0.88
Involuntary closure of eyelids in parkinsonism. Electrophysiological evidence for prolonged inhibition of the levator palpebrae muscles. J Neurol Sci (1988) 0.86
Familial communicating syringomyelia. J Neurol Sci (1978) 0.83
Autosomal dominant endosteal hyperostosis. Report of a Spanish family with neurological involvement. Clin Genet (1987) 0.83
Idiopathic torsion dystonia as described by Barraquer-Roviralta. Adv Neurol (1988) 0.82
Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis. Acta Psychiatr Scand (1985) 0.81
Communicating syringomyelia following cured tuberculous meningitis. J Neurol Sci (1974) 0.80
[Neurological complications of Mediterranean boutonneuse fever. Presentation of a case of acute encephalomeningomyelitis and review of the literature]. Neurologia (1999) 0.80
Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. Parkinsonism Relat Disord (1995) 0.80
Early detection of Huntington's disease. Blink reflex and levodopa load in presymptomatic and incipient subjects. J Neurol Neurosurg Psychiatry (1981) 0.78
Effectiveness of clonazepan in startle-induced seizures. Epilepsia (1979) 0.78
[Palm-chin reflex in Parkinson's disease]. Arch Neurobiol (Madr) (1977) 0.78
[Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. Rev Neurol (2000) 0.78
[Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements]. Neurologia (1989) 0.78
Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. Clin Neuropharmacol (1992) 0.77
Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study. J Neural Transm (Vienna) (2004) 0.76
Dementia in Idiopathic hypoparathyroidism. Rapid efficacy of alfacalcidol. Arch Neurol (1982) 0.76
[Patient care in a hospital based unit for treating Parkinson's disease and movement disorders: a 3-year prospective study]. Neurologia (1994) 0.76
[Alzheimer's disease]. Rev Clin Esp (1995) 0.75
[Neurocysticercosis among Latin American emigrants]. Rev Clin Esp (1990) 0.75
[Movement disorders in Hashimoto's encephalopathy]. Rev Neurol (2007) 0.75
Premorbid dietetic habits and risk for Parkinson's disease. Parkinsonism Relat Disord (1997) 0.75
[Severe dysphagia in Huntington's chorea with associated scleroderma]. Rev Clin Esp (1971) 0.75
[Drug-induced and masked drug parkinsonism]. Rev Neurol (1996) 0.75
[Caudate hemorrhage: a frequent diagnostic error]. Rev Clin Esp (1992) 0.75
[Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time]. Rev Clin Esp (1980) 0.75
Lightning pains in ankylosing spondylitis: response to carbamazepine. Arch Neurol (1983) 0.75
[Changeable aspects in the epidemiology of Parkinson disease (analysis of 262 cases during a period of 9 years]. Rev Clin Esp (1980) 0.75
[Developing symptomatology in treated tabes dorsalis]. Rev Clin Esp (1982) 0.75
[Immunosuppression in subacute sclerosing panencephalitis. A controlled study on the evolutive status of cerebrospinal fluid gamma globulin]. Rev Clin Esp (1976) 0.75
[Information about the diagnosis: a subjective experience of patients with multiple sclerosis and rheumatoid arthritis]. Rev Neurol (1998) 0.75
Dystonia in Spain: study of a Gypsy family and general survey. Adv Neurol (1976) 0.75
[Intravenous penicillin treatment in neurosyphilis]. Arch Neurobiol (Madr) (1982) 0.75
[Multiple calcifying hemangiomas of the brain and the blue rubber bleb nevus syndrome]. Arch Neurobiol (Madr) (1983) 0.75
Fusiform aneurysm of the scalp: an unusual cause of focal headache in Marfan syndrome. Headache (2002) 0.75
[Familial amyotrophic lateral sclerosis. Critic of its classification and analysis of 14 families of Spanish origin]. Rev Clin Esp (1978) 0.75
Acetylator polymorphism in multiple sclerosis. Acta Neurol Scand (1994) 0.75
[Indications of anticoagulants in cerebral ischemia]. Med Clin (Barc) (1987) 0.75
[Progressive supranuclear paralysis. Critical review, with a note on verbal expression disorders and action of L-dopa]. Arch Neurobiol (Madr) (1972) 0.75
Startle epilepsy complicating Down syndrome during adulthood. Ann Neurol (1980) 0.75
[Clinical value of the palmomental reflex in cerebral tumors]. Acta Neurol Latinoam (1976) 0.75
[Dominant autosomal cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A review]. Neurologia (2002) 0.75
Prognosis in hereditary amyotrophic lateral sclerosis. Arch Neurol (1977) 0.75
Epidemiological assessment of levodopa use in Cuba: 1993-1998. Pharmacoepidemiol Drug Saf (2006) 0.75
[Flexion spasms associated with tuberous sclerosis: long-term prognosis]. Rev Clin Esp (1980) 0.75
[Abnormal reabsorption of cerebrospinal fluid in progressive generalized paralysis. A new pathogenetic factor]. Arch Neurobiol (Madr) (1980) 0.75
[Cerebral moya-moya disease with bilateral kidney infarction (author's transl)]. Med Clin (Barc) (1981) 0.75
[Nociceptive reflex of the orbicularis oculi. Study in normal subjects and in peripheral facial lesions]. Arch Neurobiol (Madr) (1974) 0.75
[Sporadic myoclonus and convulsions induced by photostimulation in Alzheimer's disease]. Actas Luso Esp Neurol Psiquiatr (1970) 0.75
[Torsion dystonia: historical evolution with a note on the Spanish contribution]. Arch Neurobiol (Madr) (1986) 0.75
Flail-arm variant of amyotrophic lateral sclerosis in a Spanish soccer player. Eur J Neurol (2012) 0.75
Preclinical EEG abnormalities in subacute sclerosing panencephalitis. Neurology (1981) 0.75
[Aggravation of Parkinson's disease after inadequate use of levodopa in controlled-release preparations]. Neurologia (1995) 0.75
[Causes and prognosis of convulsive epileptic status. An analysis of 40 consecutive cases]. Rev Clin Esp (1974) 0.75
[Facioscapulohumeral inflammatory myopathy: long-term prognosis and nosologic characterization]. Neurologia (1990) 0.75
[Abnormal movements in a case of extrapontine myelinolysis. Review of the literature]. Rev Neurol (1998) 0.75
Orbicularis oculi "myotonia" in hypothyroid myopathy. Eur Neurol (1973) 0.75
Focal asterixis caused by a small putaminal hemorrhage. Mov Disord (1986) 0.75
[Subclinical leukoencephalopathy caused by methotrexate]. Neurologia (1990) 0.75
[Essential tremor in the elderly: incidence in hospital admissions for non-neurologic reasons]. Neurologia (1989) 0.75
[Frequency of neurocysticercosis at a hospital in Madrid (1980-1989)]. Arch Neurobiol (Madr) (1990) 0.75
Acute myelopathy in adulthood as a delayed consequence of radiation therapy during early infancy. J Neurol (1999) 0.75
[Familial spastic paraparesis: phenotypic variant of adrenoleukodystrophy]. Neurologia (1990) 0.75
[Juvenile myoclonic epilepsy: a prospective study of 13 cases]. Neurologia (1990) 0.75
[Neurosyphilis. Changes in its hospital incidence in a span of 14 years]. Rev Clin Esp (1985) 0.75
[Transplants in Parkinson's disease: many questions awaiting answers]. Rev Clin Esp (1988) 0.75
High-dose intravenous-penicillin in neurosyphilis: effect on intrathecal synthesis of IgG, IgM, IgA and IgD. Acta Neurol Scand (1990) 0.75
[Therapy of progressive supranuclear paralysis. Effect of methysergide and bromocriptine on various psychoneurologic and motor functions]. Rev Clin Esp (1979) 0.75
[Communicant syringomyelia as a delayed complication of cured meningeal tuberculosis]. Rev Clin Esp (1974) 0.75
[Generalized cortical (Van Buchem) hyperostosis]. Rev Clin Esp (1986) 0.75
[A study made on a data base of 2,471 patients with Parkinson disease and disorders of movement in Health District 1 of the autonomous region of Madrid. Observed demographic changes over 8 year-period]. Rev Neurol (2000) 0.75
[Dopamine agonists situation in Parkinson disease]. Rev Neurol (2002) 0.75
[Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations]. Neurologia (2007) 0.75
[The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study]. Neurologia (1996) 0.75
[Syphilis in current neurology. 1]. Arch Neurobiol (Madr) (1969) 0.75
Familial Alzheimer's disease presenting as levodopa-responsive parkinsonism. Adv Neurol (1987) 0.75